[Pain and neuroborreliosis].
Pain is one of the presenting symptoms in acute neuroborreliosis. Classically, acute neuroborreliosis--also known in Europe as Bannwarth's syndrome--is a combination of radicular pain, cranial neuritis and peripheral radiculitis and inflammatory changes of the CSF. The prognosis following antibiotic therapy is favorable. At least in its early stages, however, the diagnosis neuroborreliosis might be missed or mistaken. Thus, targeted assessment of typical signs is needed to expedite examination of the CSF which then permits definitive diagnosis.
Berthele
A
A
Neurologische Klinik derTU München.
Tölle
T R
TR
D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015748:Borrelia burgdorferi Group; D002439:Cefotaxime / Q000008:administration & dosage / Q000627:therapeutic use; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D020918:Complex Regional Pain Syndromes / Q000209:etiology; D003937:Diagnosis, Differential; D006261:Headache / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D020852:Lyme Neuroborreliosis / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D010146:Pain / Q000188:drug therapy / Q000209:etiology*; D011843:Radiculopathy / Q000175:diagnosis / Q000209:etiology; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D000700:Analgesics; D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D002439:Cefotaxime